EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
Before the summer, FTI consulting organised a meeting on compounding on behalf of EUCOPE (see my notes from the meeting HERE). Over the summer, FTI drafted its own report on the meeting, which is a selective summary of the meeting (see HERE). Comments to this draft from our side are currently being developed. In addition, to the report, FTI also shared their interested in continuing discussions with stakeholders. These discussions should lead towards the development of a common position since in accordance with FTI’s view consensus emerged around a number of key principles to prescribe and dispense compounded products.
Overall, EDQM is very interested in including our expertise in the work of their committees. Please have a look at the factsheet (see HERE) to learn more about the different committees operating in the field of pharmaceuticals and pharmaceutical care.
EDQM – traceability of medicines in the hospital sector
Frederic Broise (lead of the Committee of Experts on quality and safety standards in pharmaceutical practices and pharmaceutical care (CD-P-PH/PC)) would be interested in the engagement of an expert from EAHP’s membership in a project related to the harmonisation of the tractability of medicines in the hospital sector is envisioned. The EAHP expert should engage with the member state representatives of the CD-P-PH/PC by sharing knowledge from the field. This would entail attendance of face-to-face meetings which are currently organised once per year as well as the active engagement throughout the year in the work of the CD-P-PH/PC (i.e. via email or through participation in conference calls).
Two engagement possibilities have been identified, namely
A combination of both possibilities was also identified as an option.
See HERE further information shared by EDQM (updated 17 September).
EDQM – European Paediatric Formulary project
Dirk approached us since he would like on the one hand to present his European Paediatric Formulary project to a wider hospital pharmacy audience (possibly at Congress or during the members meeting). On the other hand, he is interested in cooperating more closely with us. He is open to a discussion on this subject. He already suggested the provision of early feedback from EAHP to new projects EDQM works on to have a complete feedback from a large number of countries, or the sharing of questions with our network on formulations where EDQM has not found adequate data. He is convinced that our members could help EDQM to learn more about ongoing on standardisation of extemporaneous preparations that they are not fully aware of.
NM prepared a document (see HERE) relating our Statements to the SDGs.
Romania will take over the Council Presidency from Austria in January 2019. Romania is currently putting together its programme. On health they are considering to focus on AMR and access to medicines which might include shortages. Given that the presidency is not very organised there is still a window for us to introduce ourselves to the health attaché in order to influence their programme.
The European elections will take place In May 2019 (from 23rd to 26th depending of the country). The European citizens will elect the new 705 MEPs (Members of the European Parliament). EAHP can use this political momentum to make a political campaign in direction to MEPs, national representatives and/or citizens. This campaign could have different objectives (exclusive or not) as:
In terms of communication design, we could draw inspiration from other campaigns such as those of EPHA and EPF.
The policy and advocacy priorities of EAHP currently focus on implementing the 44 European Statements of Hospital Pharmacy, creating a Common Training Framework for hospital pharmacy in Europe, levering the role of the hospital pharmacist in combatting antimicrobial resistance, securing EU level action on the pan-European health threat of medicines shortages and enabling the rational use of medicines. Should these be kept for 2018/2019?
Please find HERE the draft suggestion for EAHP’s endorsement strategy. In addition to reviewing the document the Board also need to determine if we want to appendix the ‘association’s procedure for the review of endorsement requests’ and if we want to offer anything to show that we non-actively support a statement/policy. Linked to the below discussion on EAHP ‘opinions’ we need to determine the term we want to use for ‘statements’ by the association that are not ‘position papers’.
See HERE the annual report business case which was prepared in accordance with the action item of the April Board meeting.
PH pointed out that many professional associations publish their position papers as open access articles in their journals. Would this be something that we should also consider?
We need to agree on a term that can be used for short responses by the EAHP Board on current EU affairs in order not to confuse these ‘statements’ with our ‘position papers’
Marcin from Poland reached out to the office, because needed information on minimum employment standards in Europe for a meeting with his Ministry. We collected some information from our members and shared it with Marcin. In relation to this email Benoit Hue suggested that this subject could be of interest for a publication in the EJHP on the Polish case/to give an overview on the situation in Europe.
1st public hearing
Information on the outcome / lessons learnt report from our first public hearing held last September for valproate (see HERE)
Shortages event
EMA/HMA have officially announced that their event on ‘access to medicines’ will take place on 8 November.
EFPIA event
EFPIA is organising an event titled ‘A shared vision for health’ on 29 November (invitation see HERE).
MOIC
EAHP and MOIC signed MoU (see HERE)
Invitation to EAHP to join the Delphi Expert Panel – IMI PARADIGM Project
PARADIGM (Patients Active in Research and Dialogues for an Improved Generation of Medicines) a project funded by the IMI fund (EFPIA and Commission lead research initiative) reached out to us to check if we are intrusted in joining their Delphi consultation. More information (letter HERE; project information HERE; project outreach HERE)
IHE Conference
We need to determine who wants to join the IHE conference (see announcement in Newsletter HERE).
Clinical trials/orphan drugs
Marc Dooms shared an article with Jennie (‘From promising molecules to orphan drugs: Early clinical drug development’) and highlighted his experience on doing clinical trials with rare diseases patients.
Politico Pro
SK requested a trial run for Politico Pro which will start on 17 September. Politico Pro could be helpful for the work of the policy team (the trial run will show that). However, the high costs of this service (€ 7 429 per year for 5 users) might outweigh the benefits. An oral report on Politico Pro will be presented at the Board meeting.
Medicines for Europe
Medicines for Europe is awarding the value-added medicines award to healthcare professionals (more information HERE). They asked us to promote their award. PH and KN already voiced their agreement with including information in our EU-Monitor.
EURORDIS conference partnership request
EURORDIS-Rare Diseases Europe invited us to become an official partner of the 3rd Multi-Stakeholder Symposium entitled “Let’s make a pact for the future to sustainably improve patients’ access to therapies for rare diseases”, a EURORDIS initiative, to be held on 13-14 February 2019 at the Crowne Plaza Hotel in Brussels, Belgium. (see concept paper HERE). We had agreed to a similar request during the February Board meeting for one of their other events.
